Aras Azadian

Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has entered into a new sub-license agreement with VB Brands California LLC and Player Holdings LLC to exclusively commercialize its Viola-branded products in the United Kingdom territory where the company has entered into a sub-licensing agreement...

The Benzinga Cannabis Capital Conference in Chicago, September 13-14, will celebrate the most recognized Latin American cannabis companies. This year's attendees will have the opportunity to meet the best Latin American brands in the industry that entered the emerging market and knew how to...

Avicanna (OTCQX: AVCNF), a biopharmaceutical company focused on cannabinoid-based products, released its Q2 2022 highlights: 6-month revenue of $2.14 million, representing 101% increase from the same period in the prior year, supported by increased international and licensing revenue...

Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products has entered into an intellectual property licensing & royalty agreement with Ei.Ventures, Inc. to develop...

Regulation is among the factors inhibiting the flow of capital to cannabis innovation. Institutions are afraid to invest, and “big pharma is not coming in as we would like to see happen.” That is according to Aras Azadian, who joined the Benzinga Cannabis Capital Conference in Miami...

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development and commercialization of plant-derived medical and pharmaceutical cannabinoid-based products, has entered into an exclusive license and supply agreement with an established South American...

Avicanna Inc. (OTCQX: AVCNF) (TSX: AVCN) (FSE: 0NN) has expanded its R&D collaboration with Bio-Gate AG with a 5-year exclusive distribution agreement for Pura H&W branded CBD derma-cosmetics. Avicanna and Bio-Gate are expanding their existing research collaboration with the commercial...

Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) announced that it has executed a non-binding term sheet with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to assess entering into a strategic partnership comprising of three strategic pillars, including: The registration and...

Avicanna Inc. (TSX:AVCN) (OTCQX: AVCNF) (FSE:0NN) provided fourth quarter 2021 results and highlights, as well as fiscal 2022 guidance. “During 2021 we forged our path within the Canadian market and demonstrated our potential as a biopharmaceutical company with the commercialization of our...

Original publication date: November 9, 2020 4:30 pm Much of cannabis’ disruptive potential lies in the plant’s ability to produce cannabinoids like THC and CBD. When it comes to rare cannabinoids, however, a different approach might yield better results. Scientists have found...

Aurora Announces Changes To Management Team Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) revealed Tuesday that it has tapped Chitwant Kohli to serve on its board of directors. Kohli brings extensive knowledge having a successful career as a senior financial executive with significant...

Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Wednesday the US launch and commercialization of its proprietary and clinically backed derma-cosmetics brand, Pura H&W. Pura H&W's product line will hit shelves through an...

Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE:0NN) announced on Monday the launch of re+PLAY sports recovery-based CBD brand through a partnership with Harrington Wellness, founded by NBA veteran Al Harrington. The brand’s initial product offerings...

Dama Financial Appoints Industry Veteran Ed Labry As Executive Chairman Of Board Dama Financial, a provider of access to financial services for the cannabis industry, said Wednesday that it has named industry veteran Ed Labry as executive chairman of the board. Labry brings vast experience, having...

CBD-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE:0NN) reported its third-quarter financial results Friday, revealing a gross revenue increase of 24% sequentially and 260% compared to the first three months of 2021 to roughly CA$1,007,033 ($987,967). The reported...